AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Aspira Women's Health Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.22−0.01 (-2.61%)
Close on Oct 19, 2026
- Market cap
- $9.91M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Dec 31, 2025, from 13F filings
Held by institutions
0.0%
0M of 47M shares
Institutional holders
1
1 new, 1 sold out
Net institutional buying
-0M
In Q4 2025
Insider trades, 12 months
1 buys · 0 sales
Net bought $100.00K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Schuler Jack W | 4,052,587 | 8.70% | 13D (active) amendment | Jun 5, 2026 |
Top institutional holders
13F holdings as of Dec 31, 2025
| Holder | Shares | % of AWHL | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Motiv8 Investments LLC | 33 | 0.00% | $0 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q4 2025 | 1 | 0M | 0.0% | 1 / 0 | 0 / 1 | 0M | 0M |
| Q3 2025 | 1 | 0M | 0.0% | 0 / 0 | 1 / 1 | 0M | 0M |
| Q2 2025 | 2 | 0M | 0.2% | 0 / 1 | 1 / 23 | 0M | 1M |
| Q1 2025 | 25 | 1M | 1.9% | 3 / 9 | 5 / 4 | 0M | 1M |
| Q4 2024 | 26 | 1M | 3.1% | 4 / 4 | 9 / 3 | 0M | 1M |
| Q3 2024 | 25 | 2M | 5.1% | 5 / 7 | 6 / 5 | 1M | 0M |
| Q2 2024 | 26 | 1M | 3.0% | 5 / 9 | 5 / 2 | 0M | 1M |
| Q1 2024 | 23 | 2M | 4.1% | 2 / 10 | 4 / 3 | 1M | 0M |
| Q4 2023 | 24 | 1M | 1.5% | 5 / 10 | 3 / 5 | 0M | 0M |
| Q3 2023 | 24 | 1M | 1.4% | 4 / 9 | 7 / 2 | 0M | 0M |
| Q2 2023 | 22 | 1M | 1.1% | 22 / 0 | 0 / 0 | 1M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Nicole Sandford | Chief Executive Officer, Director | 83,668 | 0.18% | Oct 28, 2024 |
| John Strahley | Chief Financial Officer | – | – | Jul 17, 2026 |
| Brian Hungerford | Chief Financial Officer | – | – | Sep 4, 2025 |
| Michael William Buhle | Chief Executive Officer | – | – | May 27, 2025 |
| James C. Crawford | Vice President of Finance | – | – | Mar 24, 2025 |
| Sandra Milligan | Interim CEO | 13,644 | 0.03% | Jan 29, 2025 |
| John A. Kallassy | Interim CFO | – | – | Nov 14, 2024 |
| Jeffrey k. cohen | Director | 457,028 | 0.98% | May 29, 2026 |
| John D. Fraser | Director | 854,162 | 1.83% | May 29, 2026 |
| Cynthia D. Hundorfean | Director | – | – | Dec 4, 2025 |
| Jane Pine Wood | Director | – | – | Dec 3, 2025 |
| Winfred Parnell | Director | 71,209 | 0.15% | Dec 3, 2025 |
| Ellen Beausang | Director | 6,458 | 0.01% | Dec 3, 2025 |
| Ellen O'Connor Vos | Director | 73,989 | 0.16% | Jun 6, 2025 |
| John Phillip Ragard | Director | 134,734 | 0.29% | Jun 6, 2025 |
| Stefanie L. Cavanaugh | Director | 78,726 | 0.17% | Jun 5, 2025 |
| Jannie Prestridge Herchuk | Director | 82,502 | 0.18% | Jun 5, 2025 |
| Celeste Rachelle Fralick | Director | 55,665 | 0.12% | Apr 1, 2025 |
| Jack W. Schuler | 10% owner | 4,052,587 | 8.69% | Jun 9, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jack W. Schuler 10% owner | Jun 5, 2026 | Buy | +222,222 | $0.45 | $100.00K | 4,046,051 |
| John D. Fraser Director | Sep 17, 2025 | Buy | +16,389 | $0.45 | $7.38K | 566,393 |
| Jeffrey k. cohen Director | Sep 17, 2025 | Other | +11,112 | $0.45 | $5.00K | 386,018 |
| Jeffrey k. cohen Director | Sep 17, 2025 | Buy | +55,556 | $0.45 | $25.00K | 374,906 |
| Jack W. Schuler 10% owner | Sep 17, 2025 | Buy | +1,111,111 | $0.45 | $500.00K | 3,823,829 |
| Jeffrey k. cohen Director | Sep 17, 2025 | Buy | +55,556 | $0.45 | $25.00K | 375,697 |
| John D. Fraser Director | Sep 17, 2025 | Buy | +16,389 | $0.45 | $7.38K | 566,393 |
| Ellen O'Connor Vos Director | Jun 4, 2025 | Option exercise | +5,312 | – | – | 73,989 |
| John Phillip Ragard Director | Jun 4, 2025 | Option exercise | +4,844 | – | – | 134,734 |
| Winfred Parnell Director | Jun 4, 2025 | Option exercise | +5,156 | – | – | 71,209 |
| Stefanie L. Cavanaugh Director | Jun 4, 2025 | Option exercise | +5,937 | – | – | 78,726 |
| Jannie Prestridge Herchuk Director | Jun 4, 2025 | Option exercise | +8,437 | – | – | 82,502 |
| Ellen Beausang Director | Jun 4, 2025 | Option exercise | +4,843 | – | – | 6,458 |
| Jeffrey k. cohen Director | May 13, 2025 | Award | +11,653 | $0.07 | $816 | 60,913 |
| Jeffrey k. cohen Director | May 9, 2025 | Award | +44,260 | $0.07 | $3.10K | 49,260 |
| Ellen O'Connor Vos Director | Mar 31, 2025 | Option exercise | +5,313 | – | – | 68,677 |
| Celeste Rachelle Fralick Director | Mar 31, 2025 | Option exercise | +5,000 | – | – | 55,665 |
| John Phillip Ragard Director | Mar 31, 2025 | Option exercise | +4,843 | – | – | 129,890 |
| Ellen Beausang Director | Mar 31, 2025 | Option exercise | +1,615 | – | – | 1,615 |
| Stefanie L. Cavanaugh Director | Mar 31, 2025 | Option exercise | +5,938 | – | – | 72,789 |
| Jannie Prestridge Herchuk Director | Mar 31, 2025 | Option exercise | +8,438 | – | – | 74,065 |
| Winfred Parnell Director | Mar 31, 2025 | Option exercise | +5,156 | – | – | 66,053 |
| Sandra Milligan Interim CEO | Jan 8, 2025 | Tax withholding | −6,356 | $0.70 | $4.45K | 13,644 |
| Sandra Milligan Interim CEO | Dec 31, 2024 | Option exercise | +20,000 | – | – | 20,000 |
| Stefanie L. Cavanaugh Director | Dec 31, 2024 | Option exercise | +5,937 | – | – | 66,851 |
| Sandra Milligan Interim CEO & President | Dec 31, 2024 | Option exercise | +20,000 | – | – | 20,000 |
| John Phillip Ragard Director | Dec 31, 2024 | Option exercise | +4,844 | – | – | 125,047 |
| Ellen O'Connor Vos Director | Dec 31, 2024 | Option exercise | +5,312 | – | – | 63,364 |
| Jannie Prestridge Herchuk Director | Dec 31, 2024 | Option exercise | +8,437 | – | – | 65,627 |
| Winfred Parnell Director | Dec 31, 2024 | Option exercise | +5,157 | – | – | 60,897 |
| Celeste Rachelle Fralick Director | Dec 31, 2024 | Option exercise | +5,000 | – | – | 50,665 |
| John Phillip Ragard Director | Sep 30, 2024 | Option exercise | +4,844 | – | – | 120,203 |
| Ellen O'Connor Vos Director | Sep 30, 2024 | Option exercise | +5,313 | – | – | 58,052 |
| Jannie Prestridge Herchuk Director | Sep 30, 2024 | Option exercise | +8,438 | – | – | 57,190 |
| Celeste Rachelle Fralick Director | Sep 30, 2024 | Option exercise | +5,000 | – | – | 45,665 |
| John Phillip Ragard Director | Sep 30, 2024 | Option exercise | +4,844 | – | – | 120,203 |
| Stefanie L. Cavanaugh Director | Sep 30, 2024 | Option exercise | +5,938 | – | – | 60,914 |
| Winfred Parnell Director | Sep 30, 2024 | Option exercise | +5,156 | – | – | 55,740 |
| Ellen O'Connor Vos Director | Aug 12, 2024 | Award | +16,593 | – | – | 52,739 |
| Winfred Parnell Director | Aug 12, 2024 | Award | +15,803 | – | – | 50,584 |
| Celeste Rachelle Fralick Director | Aug 12, 2024 | Award | +15,381 | – | – | 40,665 |
| Stefanie L. Cavanaugh Director | Aug 12, 2024 | Award | +16,804 | – | – | 54,976 |
| Jannie Prestridge Herchuk Director | Aug 12, 2024 | Award | +20,017 | – | – | 48,752 |
| Jack W. Schuler 10% owner | Jul 9, 2024 | Buy | +6,536 | – | – | 6,536 |
| Jannie Prestridge Herchuk Director | Jul 9, 2024 | Award | +4,902 | – | – | 28,735 |
| Ellen O'Connor Vos Director | Jul 9, 2024 | Award | +3,268 | – | – | 36,146 |
| Winfred Parnell Director | Jul 9, 2024 | Award | +3,268 | – | – | 34,781 |
| Stefanie L. Cavanaugh Director | Jul 9, 2024 | Award | +3,268 | – | – | 38,172 |
| Nicole Sandford CEO, Director | Jul 9, 2024 | Award | +13,072 | – | – | 83,668 |
| Nicole Sandford Chief Executive Officer, Director | May 31, 2024 | Buy | +9,493 | $2.42 | $22.97K | 70,596 |
| Jack W. Schuler 10% owner | Jan 26, 2024 | Buy | +28,500 | – | – | 1,912,156 |
| Nicole Sandford President & CEO, Director | Jan 26, 2024 | Buy | +2,400 | – | – | 61,103 |
| Minh Hoang Merchant Secretary & General Counsel | Dec 6, 2023 | Sale | −980 | $3.37 | $3.30K | 0 |
| Nicole Sandford President & CEO, Director | Dec 6, 2023 | Buy | +5,000 | $3.36 | $16.80K | 58,703 |
| Minh Hoang Merchant Secretary & General Counsel | Nov 17, 2023 | Award | +10,000 | – | – | 26,865 |
| Torsten Hombeck Chief Financial Officer | Nov 17, 2023 | Award | +30,000 | – | – | 33,000 |
| Torsten Hombeck Chief Financial Officer | Sep 8, 2023 | Buy | +2,246 | $4.30 | $9.66K | 3,000 |
| Nicole Sandford President & CEO, Director | Aug 29, 2023 | Award | +26,467 | – | – | 53,703 |
| Nicole Sandford President and CEO, Director | Aug 29, 2023 | Award | +26,367 | – | – | 187,499 |
| Celeste Rachelle Fralick Director | Aug 28, 2023 | Award | +13,252 | – | – | 25,284 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.